Host Risk Factors for Tuberculosis.

Tuberculosis anemia. diabetes epigenetic modification malnutrition

Journal

Infectious disorders drug targets
ISSN: 2212-3989
Titre abrégé: Infect Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269158

Informations de publication

Date de publication:
03 Sep 2024
Historique:
received: 14 01 2024
revised: 22 05 2024
accepted: 12 06 2024
medline: 4 9 2024
pubmed: 4 9 2024
entrez: 4 9 2024
Statut: aheadofprint

Résumé

Tuberculosis (TB) spreads through droplets that contain Mycobacterium tuberculosis (Mtb) and can infect susceptible people. Due to different risk factors, people have different susceptibility ranges towards TB. The risk factors are classified into three main groups, includ-ing bacterial, environmental, and host factors. Literature review reveals that the most important host risk factors are aging, male gender, genetics, epigenetics, having an impaired immune system, diabetes, malignancy, malnutrition, anemia, and pregnancy. The risk factors contribute to the increase in TB cases through inflammation, increased contact with TB patients, disrup-tion of immune genes, changes in gene expression, increased activity of Mtb, damage to cellu-lar immunity, reactivation of Latent TB Infection (LTBI), increased susceptibility to TB, com-promised immunity, and changes in the proportion of T cell subgroups, respectively. Therefore, identification of the infection source and high-risk people and timely treatment of the patients can reduce TB mortality and help control the disease.

Identifiants

pubmed: 39229984
pii: IDDT-EPUB-142734
doi: 10.2174/0118715265304343240722190414
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Vahid Asgharzadeh (V)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Seyyed Amin Seyyed Rezaei (SA)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Asgharzadeh (M)

Biotechnology Research Center and Faculty of Paramedicine, Tabriz Univer-sity of Medical Sciences, Tabriz, Iran.

Jalil Rashedi (J)

Tuberculosis and Lung Disease Research Center and Faculty of Paramedicine, Ta-briz University of Medical Sciences, Tabriz, Iran.

Hossein Samadi Kafil (H)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Jalaei Nobari (H)

Department of Islamic studies, Faculty of Paramedicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Ahmad Ali Khalili (AA)

Department of Cardiovascular Surgery, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mortaza Raeisi (M)

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mahdi Asghari Ozma (MA)

Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Behroz Mahdavi Poor (B)

Department of Laboratory Sciences, Faculty of Paramedicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Gene Therapy Research Center, Faculty of Paramedicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Classifications MeSH